What is MobileSmith?
MobileSmith Health (OTCBB:MOST) operates as a pivotal player in the digital health and mobile development sector. The company specializes in creating intuitive, patient-centric technology ecosystems designed to optimize the patient journey from pre-procedural preparation to post-procedural recovery. By leveraging embedded EMR integration and sophisticated adherence tracking dashboards, MobileSmith provides healthcare providers with the visibility required to improve clinical outcomes and operational efficiency.
The firm's core value proposition lies in its ability to reduce procedural cancellations and complications, thereby streamlining the delivery of care. Through its robust platform, MobileSmith facilitates a seamless connection between clinical workflows and patient engagement, positioning itself as an essential partner for healthcare institutions seeking to modernize their digital infrastructure and improve overall patient adherence metrics.
How much funding has MobileSmith raised?
MobileSmith has raised a total of $892K across 2 funding rounds:
Debt
$350K
Debt
$542K
Debt (2020): $350K with participation from PPP
Debt (2021): $542K led by PPP
Key Investors in MobileSmith
PPP
Public-Private Partnership
What's next for MobileSmith?
With the recent infusion of capital, MobileSmith is poised to accelerate its product development roadmap and deepen its integration within existing hospital EMR systems. The strategic focus will likely shift toward expanding its market reach and enhancing the predictive analytics capabilities of its adherence tracking dashboards. By prioritizing scalability and interoperability, the company aims to further reduce the friction in the patient journey, ultimately driving higher value for healthcare providers and improving long-term health outcomes.
The company's forward-looking strategy involves leveraging its current financial standing to solidify its role as a leader in mobile health technology. As the industry continues to shift toward value-based care, MobileSmith's focus on data-driven patient engagement will be critical in maintaining its competitive advantage and fostering sustainable growth in the enterprise health market.
